HEPATIC IMPAIRMENT
Clinical trials for HEPATIC IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests: how does a failing liver handle a new drug?
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new medicine, BI 3000202, is processed by the body in people with and without liver problems. It will enroll 44 adults, including healthy volunteers and people with varying degrees of liver impairment. Each participant takes a singl…
Matched conditions: HEPATIC IMPAIRMENT
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Early safety check: how liver health affects new medication
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new drug called BMS-986435 behaves in the body of people with normal liver function compared to those with mild or moderate liver impairment. The trial will involve 24 participants who will receive a single dose of the drug, then re…
Matched conditions: HEPATIC IMPAIRMENT
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC